Correction: Tofacitinib for the Treatment of Moderately to Severely Active Ulcerative Colitis: A Systematic Review, Network Meta-Analysis and Economic Evaluation

BMJ Open Gastroenterology - United Kingdom
doi 10.1136/bmjgast-2019-000302corr1
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

BMJ

Related search

Editorial: Tacrolimus vs. Anti-Tumour Necrosis Factor Agents for Moderately to Severely Active Ulcerative Colitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Efficacy and Safety of Rectal 5-Aminosalicylic Acid Versus Corticosteroids in Active Distal Ulcerative Colitis: A Systematic Review and Network Meta-Analysis

Scientific Reports
Multidisciplinary
2017English

EFFICACY AND SAFETY OF TOFACITINIB IN ULCERATIVE COLITIS (Review)

Koloproktologia
2018English

Α Systematic Review of Economic Evaluations of Biological Therapies for the Treatment of Ulcerative Colitis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Treatment of Ulcerative Colitis in the Elderly: A Systematic Review

Clinical Medicine Insights: Geriatrics
GerontologyGeriatrics
2013English

Efficacy and Safety of Biologic Agents and Tofacitinib in Moderate-To-Severe Ulcerative Colitis: A Systematic Overview of Meta-Analyses

United European Gastroenterology Journal
OncologyGastroenterology
2019English

Bone Mineral Density Is Negatively Correlated With Ulcerative Colitis: A Systematic Review and Meta-Analysis

Clinical and Translational Medicine
MedicineMolecular Medicine
2020English

Risk of Colorectal Cancer in Asian Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis

Lancet Gastroenterology and Hepatology, The
HepatologyGastroenterology
2017English

Exam 2: Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-Analysis

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy